Maximilian Rabil, MD
Hospital ResidentAbout
Research
Publications
2025
Harmonizing environmental and economic forces in urologic care.
Rabil M, Choksi A, Leapman M. Harmonizing environmental and economic forces in urologic care. Current Opinion In Urology 2025 PMID: 40948360, DOI: 10.1097/mou.0000000000001338.Peer-Reviewed Original ResearchEnvironmental impactAnthropogenic greenhouse gas emissionsSingle-use itemsGreenhouse gas emissionsEcological responsesHuman healthEconomic forcesClimate changeGas emissionsEnvironmental sustainabilityEnvironmental wasteHealthcare systemUrological careBalance approachEconomic valueLower value servicesResource consumptionMature body of researchDelivery of treatmentCare deliverySustainable practicesCare valueSustainabilityLocal marketsUrologic healthAutomated electronic medical record abstraction algorithm for radical prostatectomy outcomes
Rabil M, Jalfon M, Palencia P, Heckscher D, Kong V, Golos A, Richmond R, Chess A, Kim I, Leapman M, Cavallo J. Automated electronic medical record abstraction algorithm for radical prostatectomy outcomes. Urologic Oncology Seminars And Original Investigations 2025 PMID: 40885622, DOI: 10.1016/j.urolonc.2025.07.028.Peer-Reviewed Original ResearchInter-rater reliabilityRobot-assisted laparoscopic radical prostatectomyRadical prostatectomyQuality improvementSurgical outcomesRadical prostatectomy outcomesLaparoscopic radical prostatectomyQuality metricsAutomated extractionSurgical marginsUrine leakICD-10Renal insufficiencyOutcome metricsPathological resultsRectal injuryUreteral obstructionText extractionCohen's kappaOutcome matchesAbstraction algorithmCosts of outcomesStatistical significanceProstatectomyAlgorithmKappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant
Mayer F, Stewart A, Varman D, Moritz A, Foster J, Owens A, Areal L, Gowrishankar R, Velez M, Wickham K, Phelps H, Katamish R, Rabil M, Jayanthi L, Vaughan R, Daws L, Blakely R, Ramamoorthy S. Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant. Molecular Psychiatry 2025, 30: 4651-4664. PMID: 40442453, PMCID: PMC12436197, DOI: 10.1038/s41380-025-03055-4.Peer-Reviewed Original ResearchAttention-deficit/hyperactivity disorderKappa-opioid receptor antagonismKappa-opioid receptorsAnomalous DA effluxDA transporterAutism spectrum disorderBipolar disorderDAT Val559D-amphetamineDA releaseAbuse liabilityTreatment of attention-deficit/hyperactivity disorderDopamine transporter variantsModulate DA releaseDA transporter functionSubstance use disordersTargeting kappa opioid receptorsKappa-opioid receptor stimulationHuman DA transporterKOR antagonismDA effluxAberrant dopamineAttention-deficit/hyperactivityDA neuronsSpectrum disorderMP33-07 AUTOMATED ABSTRACTION ALGORITHM FOR RADICAL CYSTECTOMY SURGICAL OUTCOMES
Palencia P, Rabil M, Jalfon M, Heckscher D, Richmond R, Kong V, Golos A, Chess A, Leapman M, Cavallo J. MP33-07 AUTOMATED ABSTRACTION ALGORITHM FOR RADICAL CYSTECTOMY SURGICAL OUTCOMES. Journal Of Urology 2025, 213: e1131. DOI: 10.1097/01.ju.0001110116.40703.0e.07.Peer-Reviewed Original ResearchProstate-Specific Membrane Antigen Imaging Findings and Subsequent Clinical Management Among Patients With Biochemically Recurrent Prostate Cancer
Rabil M, Ghaffar U, Long J, Westvold S, Sprenkle P, Kim I, Saperstein L, Kunst N, Wang S, Ma X, Gross C, Leapman M, Karnes R. Prostate-Specific Membrane Antigen Imaging Findings and Subsequent Clinical Management Among Patients With Biochemically Recurrent Prostate Cancer. JU Open Plus 2025, 3 DOI: 10.1097/ju9.0000000000000278.Peer-Reviewed Original ResearchMetastasis-directed therapyPSMA PET findingsPSMA-PETBiochemical recurrencePSA levelsDistant metastasisProstate cancerLocal therapyProstate-specific membrane antigen positron emission tomographyClinical managementBiochemically recurrent prostate cancerIdentification of distant metastasesNegative PSMA-PETRecurrent prostate cancerRegional nodal diseasePositron emission tomographyNodal diseaseLocal recurrenceInitial therapySystemic therapyTreatment initiationClinical outcomesImaging findingsMetastasisTreatment choicePost-vasectomy semen analysis: what is the best protocol?
Cahill E, Rabil M, Rotker K, Honig S. Post-vasectomy semen analysis: what is the best protocol? International Journal Of Impotence Research 2025, 1-5. PMID: 40155486, DOI: 10.1038/s41443-025-01052-3.Peer-Reviewed Original ResearchPost-vasectomy semen analysisAmerican Urological AssociationNon-motile spermSemen analysisPatient complianceAmerican Urological Association guidelinesFactors associated with complianceInitial clearance rateUrological AssociationPermanent sterilizationPatientsClearance ratePatient embarrassmentPatient preferencesVasectomyAzoospermiaAt-home testingClearanceIncrease complianceAlternative optionEffective formComplianceContraceptionDiscrepancies in volume: impact of Artemis segmented magnetic resonance imaging, ultrasound, and ExactVu measurements on prostate specific antigen density and National Comprehensive Cancer Network risk stratification
Rabil M, Webb L, Diaz G, Lokeshwar S, Choksi A, Sprenkle P. Discrepancies in volume: impact of Artemis segmented magnetic resonance imaging, ultrasound, and ExactVu measurements on prostate specific antigen density and National Comprehensive Cancer Network risk stratification. Central European Journal Of Urology 2025, 78: 1-4. PMID: 40371423, PMCID: PMC12073516, DOI: 10.5173/ceju.2024.0249.Peer-Reviewed Original ResearchProstate specific antigen densityProstate specific antigenNational Comprehensive Cancer NetworkMagnetic resonance imagingRisk stratificationNational Comprehensive Cancer Network risk stratificationBiopsy systemProstate cancer risk stratificationMeasure prostate volumeRandom prostate biopsyResonance imagingCancer risk stratificationComprehensive Cancer NetworkCombination of magnetic resonance imagingClinically insignificant differencesExactVu systemPSA densityProstate volumeProstate biopsyAntigen densityPatient's disease stateSpecific antigenBiopsy casesClinical impactProstate
2024
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI
Sundaresan V, Webb L, Rabil M, Golos A, Sutherland R, Bailey J, Rajwa P, Seibert T, Loeb S, Cooperberg M, Catalona W, Sprenkle P, Kim I, Leapman M. Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI. Urologic Oncology Seminars And Original Investigations 2024, 43: 193.e19-193.e26. PMID: 39706698, DOI: 10.1016/j.urolonc.2024.11.007.Peer-Reviewed Original ResearchConceptsPI-RADS 5 lesionsGG1 prostate cancerPI-RADSGG1 diseaseFusion biopsyRadical prostatectomyGleason gradeProstate cancerActive surveillanceGrade Group 1 prostate cancerSingle-institution retrospective analysisOptimal management of patientsMRI-ultrasound fusion biopsyLong-term outcome dataProstate Imaging ReportingMultivariate modelGenomic classifier scoresManagement of patientsPrimary study outcomeAssociated with upgradingMulti-institutional dataGleason upgradingTumor upgradingSurveillance biopsiesProstate MRILong-Term Outcomes of Prostate-Specific Membrane Antigen–PET Imaging of Recurrent Prostate Cancer
Kunst N, Long J, Westvold S, Sprenkle P, Kim I, Saperstein L, Rabil M, Ghaffar U, Karnes R, Ma X, Gross C, Wang S, Leapman M. Long-Term Outcomes of Prostate-Specific Membrane Antigen–PET Imaging of Recurrent Prostate Cancer. JAMA Network Open 2024, 7: e2440591. PMID: 39441595, PMCID: PMC11581571, DOI: 10.1001/jamanetworkopen.2024.40591.Peer-Reviewed Original ResearchConceptsProstate-specific antigenProstate-specific antigen levelPSMA-PETRecurrent prostate cancerBiochemical recurrenceProstate cancerLong-term outcomesProstate-specific membrane antigen positron emission tomographyEvaluation of biochemical recurrenceDetection of biochemical recurrenceLife yearsConventional imagingDefinitive local therapyPSMA PET imagingProstate cancer deathDetection of metastasesRetrospective cohort studyBase case analysisIncremental life-yearsPositron emission tomographyDecision-analytic modelLocal therapyConventional imaging strategiesDelayed TreatmentDisease courseReply to Editorial Comment on “Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy”
Rabil M, Leapman M, Cavallo J. Reply to Editorial Comment on “Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy”. Urology 2024, 193: 97-98. PMID: 39208938, DOI: 10.1016/j.urology.2024.08.054.Peer-Reviewed Original Research
News
News
- October 27, 2025
Yale Urology Research
- July 29, 2025
Yale Urology Research [Q2: April-June 2025]
- June 25, 2025
2025 Yale Urology Visiting Professor and Graduation Day
- April 15, 2025
Yale Urology Research [Q1: January-March 2025]